The Kansas Department of Health and Environment announced Monday that Kansas would resume administration of the Johnson & Johnson COVID-19 vaccine.

Administration of the Johnson & Johnson vaccine had been paused on April 13 by the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration following reports that six female recipients of the vaccine had developed rare blood clots within two weeks of vaccination. Since that announcement, a total of 15 cases of the rare blood clots, called thrombosis-thrombocytopenia syndrome, have been reported.

The CDC and FDA conducted a safety review of the vaccine and determined that the vaccine’s known and potential benefits outweigh its known and potential risks. The agencies will continue to investigate the risk of blood clotting, even though the chances of it occurring are “very low,” they said in a joint statement. Over 6.8 million doses of the Johnson & Johnson vaccine have been administered.

Kansas is expected to receive its next supply of the Johnson & Johnson vaccine the week of May 13 with 1,700 doses. Gov. Laura Kelly called the vaccine “safe and effective.”

“Today, Kansas will resume administering the Johnson & Johnson COVID-19 vaccine,” Kelly said in the release. “After a brief pause and a thorough review, the CDC and FDA have determined the vaccine is safe and effective. Whether it’s the Johnson and Johnson, Pfizer or Moderna, I strongly encourage every Kansan to get vaccinated as soon as they can.”

In Douglas County, Johnson & Johnson vaccines represent a small portion of total vaccines administered. As of April 22, 50,889 first doses of vaccines had been administered in the county, and of those 50,889 doses, 1,581 were Johnson & Johnson vaccines, or 3.1%